Milestone Pharmaceuticals (MIST) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 10, 2026, to be held virtually.

• Proxy materials are available online, with options for electronic or paper delivery.

• Shareholders are encouraged to review materials and vote electronically or by phone.

Voting matters and shareholder proposals

• Election of eight directors is up for shareholder vote.

• Appointment of PricewaterhouseCoopers LLP as external auditors is proposed.

• Amendment to the 2019 Equity Incentive Plan to increase authorized shares by 6.8 million is proposed.

• Advisory approval of executive compensation is included as a say-on-pay proposal.

Board of directors and corporate governance

• Board recommends voting in favor of all four proposals.

• List of director nominees includes Stuart M. Duty, Seth H.Z. Fischer, Lisa M. Giles, Joseph Oliveto, Joseph C. Papa, Andrew R. Saik, Michael Tomsicek, and Robert J. Wills, PhD.